nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Methotrexate—lymphatic system cancer	0.244	0.335	CbGbCtD
Perphenazine—CYP1A2—Carmustine—lymphatic system cancer	0.14	0.192	CbGbCtD
Perphenazine—CYP2C19—Teniposide—lymphatic system cancer	0.102	0.14	CbGbCtD
Perphenazine—CYP2C9—Teniposide—lymphatic system cancer	0.085	0.116	CbGbCtD
Perphenazine—CYP3A4—Cytarabine—lymphatic system cancer	0.0502	0.0688	CbGbCtD
Perphenazine—CYP3A4—Teniposide—lymphatic system cancer	0.0494	0.0677	CbGbCtD
Perphenazine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0346	0.0474	CbGbCtD
Perphenazine—CYP3A4—Vincristine—lymphatic system cancer	0.0238	0.0326	CbGbCtD
Perphenazine—Edema cerebral—Carmustine—lymphatic system cancer	0.0149	0.0551	CcSEcCtD
Perphenazine—Hypotensive—Teniposide—lymphatic system cancer	0.0112	0.0416	CcSEcCtD
Perphenazine—Brain oedema—Carmustine—lymphatic system cancer	0.00807	0.0298	CcSEcCtD
Perphenazine—Sudden death—Teniposide—lymphatic system cancer	0.00802	0.0296	CcSEcCtD
Perphenazine—Amenorrhoea—Mechlorethamine—lymphatic system cancer	0.00633	0.0234	CcSEcCtD
Perphenazine—Ileus paralytic—Vincristine—lymphatic system cancer	0.00509	0.0188	CcSEcCtD
Perphenazine—Pallor—Teniposide—lymphatic system cancer	0.00495	0.0183	CcSEcCtD
Perphenazine—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.00447	0.0165	CcSEcCtD
Perphenazine—Sudden death—Mitoxantrone—lymphatic system cancer	0.00419	0.0155	CcSEcCtD
Perphenazine—Inappropriate antidiuretic hormone secretion—Vincristine—lymphatic system cancer	0.00379	0.014	CcSEcCtD
Perphenazine—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00331	0.0123	CcSEcCtD
Perphenazine—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.0033	0.0122	CcSEcCtD
Perphenazine—Jaundice—Mechlorethamine—lymphatic system cancer	0.00303	0.0112	CcSEcCtD
Perphenazine—Retinal disorder—Methotrexate—lymphatic system cancer	0.00299	0.0111	CcSEcCtD
Perphenazine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0029	0.0107	CcSEcCtD
Perphenazine—Pancytopenia—Teniposide—lymphatic system cancer	0.00244	0.00903	CcSEcCtD
Perphenazine—Amenorrhoea—Mitoxantrone—lymphatic system cancer	0.00244	0.00902	CcSEcCtD
Perphenazine—Dysphagia—Fludarabine—lymphatic system cancer	0.00226	0.00836	CcSEcCtD
Perphenazine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00218	0.00805	CcSEcCtD
Perphenazine—Pancytopenia—Fludarabine—lymphatic system cancer	0.00215	0.00794	CcSEcCtD
Perphenazine—Sudden death—Methotrexate—lymphatic system cancer	0.00209	0.00772	CcSEcCtD
Perphenazine—Gynaecomastia—Carmustine—lymphatic system cancer	0.00206	0.00763	CcSEcCtD
Perphenazine—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.00204	0.00754	CcSEcCtD
Perphenazine—Urine output increased—Vincristine—lymphatic system cancer	0.00199	0.00736	CcSEcCtD
Perphenazine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00198	0.00734	CcSEcCtD
Perphenazine—Infection—Mechlorethamine—lymphatic system cancer	0.00197	0.00729	CcSEcCtD
Perphenazine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00189	0.00699	CcSEcCtD
Perphenazine—Polyuria—Vincristine—lymphatic system cancer	0.00182	0.00673	CcSEcCtD
Perphenazine—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.0018	0.00666	CcSEcCtD
Perphenazine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00173	0.00638	CcSEcCtD
Perphenazine—Agitation—Teniposide—lymphatic system cancer	0.00165	0.00609	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00161	0.00595	CcSEcCtD
Perphenazine—Leukopenia—Teniposide—lymphatic system cancer	0.0016	0.00593	CcSEcCtD
Perphenazine—Pancytopenia—Bleomycin—lymphatic system cancer	0.00157	0.00582	CcSEcCtD
Perphenazine—Ataxia—Carmustine—lymphatic system cancer	0.00157	0.00582	CcSEcCtD
Perphenazine—Hypertension—Teniposide—lymphatic system cancer	0.00155	0.00572	CcSEcCtD
Perphenazine—Cardiac arrest—Vincristine—lymphatic system cancer	0.00152	0.00562	CcSEcCtD
Perphenazine—Urinary retention—Vincristine—lymphatic system cancer	0.00152	0.00562	CcSEcCtD
Perphenazine—Ataxia—Vincristine—lymphatic system cancer	0.0015	0.00556	CcSEcCtD
Perphenazine—Muscular weakness—Carmustine—lymphatic system cancer	0.00148	0.00546	CcSEcCtD
Perphenazine—Confusional state—Teniposide—lymphatic system cancer	0.00148	0.00545	CcSEcCtD
Perphenazine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00146	0.00541	CcSEcCtD
Perphenazine—Infection—Teniposide—lymphatic system cancer	0.00145	0.00537	CcSEcCtD
Perphenazine—Agitation—Fludarabine—lymphatic system cancer	0.00145	0.00535	CcSEcCtD
Perphenazine—Dysphagia—Carmustine—lymphatic system cancer	0.00145	0.00535	CcSEcCtD
Perphenazine—Tachycardia—Teniposide—lymphatic system cancer	0.00143	0.00528	CcSEcCtD
Perphenazine—Leukopenia—Fludarabine—lymphatic system cancer	0.00141	0.00521	CcSEcCtD
Perphenazine—Muscular weakness—Vincristine—lymphatic system cancer	0.00141	0.00521	CcSEcCtD
Perphenazine—Pruritus—Mechlorethamine—lymphatic system cancer	0.0014	0.00519	CcSEcCtD
Perphenazine—Anorexia—Teniposide—lymphatic system cancer	0.00139	0.00516	CcSEcCtD
Perphenazine—Cough—Fludarabine—lymphatic system cancer	0.00138	0.00508	CcSEcCtD
Perphenazine—Pancytopenia—Carmustine—lymphatic system cancer	0.00137	0.00508	CcSEcCtD
Perphenazine—Hypotension—Teniposide—lymphatic system cancer	0.00137	0.00505	CcSEcCtD
Perphenazine—Convulsion—Fludarabine—lymphatic system cancer	0.00137	0.00505	CcSEcCtD
Perphenazine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00136	0.00502	CcSEcCtD
Perphenazine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00132	0.00488	CcSEcCtD
Perphenazine—Pancytopenia—Vincristine—lymphatic system cancer	0.00131	0.00485	CcSEcCtD
Perphenazine—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00131	0.00483	CcSEcCtD
Perphenazine—Dyspnoea—Teniposide—lymphatic system cancer	0.0013	0.00482	CcSEcCtD
Perphenazine—Confusional state—Fludarabine—lymphatic system cancer	0.0013	0.00479	CcSEcCtD
Perphenazine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00129	0.00475	CcSEcCtD
Perphenazine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00128	0.00472	CcSEcCtD
Perphenazine—Infection—Fludarabine—lymphatic system cancer	0.00128	0.00472	CcSEcCtD
Perphenazine—Decreased appetite—Teniposide—lymphatic system cancer	0.00127	0.0047	CcSEcCtD
Perphenazine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00126	0.00466	CcSEcCtD
Perphenazine—Anorexia—Fludarabine—lymphatic system cancer	0.00123	0.00453	CcSEcCtD
Perphenazine—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00121	0.00449	CcSEcCtD
Perphenazine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.0012	0.00444	CcSEcCtD
Perphenazine—Jaundice—Mitoxantrone—lymphatic system cancer	0.00117	0.00432	CcSEcCtD
Perphenazine—Urticaria—Teniposide—lymphatic system cancer	0.00116	0.0043	CcSEcCtD
Perphenazine—Body temperature increased—Teniposide—lymphatic system cancer	0.00116	0.00428	CcSEcCtD
Perphenazine—Erythema—Bleomycin—lymphatic system cancer	0.00116	0.00427	CcSEcCtD
Perphenazine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00115	0.00426	CcSEcCtD
Perphenazine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00115	0.00424	CcSEcCtD
Perphenazine—Oedema peripheral—Carmustine—lymphatic system cancer	0.00114	0.00422	CcSEcCtD
Perphenazine—Dysarthria—Methotrexate—lymphatic system cancer	0.00113	0.00418	CcSEcCtD
Perphenazine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00112	0.00414	CcSEcCtD
Perphenazine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00112	0.00413	CcSEcCtD
Perphenazine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.0011	0.00407	CcSEcCtD
Perphenazine—Constipation—Fludarabine—lymphatic system cancer	0.0011	0.00407	CcSEcCtD
Perphenazine—Pain—Fludarabine—lymphatic system cancer	0.0011	0.00407	CcSEcCtD
Perphenazine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.0011	0.00405	CcSEcCtD
Perphenazine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00108	0.00399	CcSEcCtD
Perphenazine—Pruritus—Teniposide—lymphatic system cancer	0.00104	0.00383	CcSEcCtD
Perphenazine—Leukopenia—Bleomycin—lymphatic system cancer	0.00103	0.00382	CcSEcCtD
Perphenazine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00102	0.00376	CcSEcCtD
Perphenazine—Erythema—Carmustine—lymphatic system cancer	0.00101	0.00373	CcSEcCtD
Perphenazine—Cough—Bleomycin—lymphatic system cancer	0.00101	0.00373	CcSEcCtD
Perphenazine—Diarrhoea—Teniposide—lymphatic system cancer	0.001	0.0037	CcSEcCtD
Perphenazine—Urine output increased—Methotrexate—lymphatic system cancer	0.000966	0.00357	CcSEcCtD
Perphenazine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000956	0.00353	CcSEcCtD
Perphenazine—Confusional state—Bleomycin—lymphatic system cancer	0.000951	0.00351	CcSEcCtD
Perphenazine—Vision blurred—Carmustine—lymphatic system cancer	0.00095	0.00351	CcSEcCtD
Perphenazine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000948	0.0035	CcSEcCtD
Perphenazine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000943	0.00349	CcSEcCtD
Perphenazine—Erythema—Mitoxantrone—lymphatic system cancer	0.000938	0.00347	CcSEcCtD
Perphenazine—Infection—Bleomycin—lymphatic system cancer	0.000937	0.00346	CcSEcCtD
Perphenazine—Agitation—Carmustine—lymphatic system cancer	0.000927	0.00343	CcSEcCtD
Perphenazine—Headache—Teniposide—lymphatic system cancer	0.000917	0.00339	CcSEcCtD
Perphenazine—Pruritus—Fludarabine—lymphatic system cancer	0.00091	0.00336	CcSEcCtD
Perphenazine—Leukopenia—Carmustine—lymphatic system cancer	0.000903	0.00334	CcSEcCtD
Perphenazine—Anorexia—Bleomycin—lymphatic system cancer	0.000899	0.00332	CcSEcCtD
Perphenazine—Agitation—Vincristine—lymphatic system cancer	0.000885	0.00327	CcSEcCtD
Perphenazine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000884	0.00327	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—lymphatic system cancer	0.000883	0.00327	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—lymphatic system cancer	0.000883	0.00327	CcSEcCtD
Perphenazine—Hypotension—Bleomycin—lymphatic system cancer	0.000881	0.00326	CcSEcCtD
Perphenazine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00088	0.00325	CcSEcCtD
Perphenazine—Convulsion—Carmustine—lymphatic system cancer	0.000874	0.00323	CcSEcCtD
Perphenazine—Hypertension—Carmustine—lymphatic system cancer	0.000871	0.00322	CcSEcCtD
Perphenazine—Leukopenia—Vincristine—lymphatic system cancer	0.000862	0.00319	CcSEcCtD
Perphenazine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000841	0.00311	CcSEcCtD
Perphenazine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000839	0.0031	CcSEcCtD
Perphenazine—Convulsion—Vincristine—lymphatic system cancer	0.000834	0.00308	CcSEcCtD
Perphenazine—Hypertension—Vincristine—lymphatic system cancer	0.000831	0.00307	CcSEcCtD
Perphenazine—Confusional state—Carmustine—lymphatic system cancer	0.00083	0.00307	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000822	0.00304	CcSEcCtD
Perphenazine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00082	0.00303	CcSEcCtD
Perphenazine—Cough—Mitoxantrone—lymphatic system cancer	0.000818	0.00302	CcSEcCtD
Perphenazine—Infection—Carmustine—lymphatic system cancer	0.000818	0.00302	CcSEcCtD
Perphenazine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000812	0.003	CcSEcCtD
Perphenazine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000809	0.00299	CcSEcCtD
Perphenazine—Pain—Bleomycin—lymphatic system cancer	0.000806	0.00298	CcSEcCtD
Perphenazine—Headache—Fludarabine—lymphatic system cancer	0.000806	0.00298	CcSEcCtD
Perphenazine—Tachycardia—Carmustine—lymphatic system cancer	0.000803	0.00297	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000801	0.00296	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—lymphatic system cancer	0.000792	0.00293	CcSEcCtD
Perphenazine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000786	0.0029	CcSEcCtD
Perphenazine—Anorexia—Carmustine—lymphatic system cancer	0.000785	0.0029	CcSEcCtD
Perphenazine—Infection—Vincristine—lymphatic system cancer	0.000781	0.00289	CcSEcCtD
Perphenazine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000772	0.00285	CcSEcCtD
Perphenazine—Hypotension—Carmustine—lymphatic system cancer	0.000769	0.00284	CcSEcCtD
Perphenazine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000765	0.00283	CcSEcCtD
Perphenazine—Infection—Mitoxantrone—lymphatic system cancer	0.00076	0.00281	CcSEcCtD
Perphenazine—Shock—Mitoxantrone—lymphatic system cancer	0.000753	0.00278	CcSEcCtD
Perphenazine—Urticaria—Bleomycin—lymphatic system cancer	0.000749	0.00277	CcSEcCtD
Perphenazine—Anorexia—Vincristine—lymphatic system cancer	0.000749	0.00277	CcSEcCtD
Perphenazine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000747	0.00276	CcSEcCtD
Perphenazine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000745	0.00276	CcSEcCtD
Perphenazine—Insomnia—Carmustine—lymphatic system cancer	0.000744	0.00275	CcSEcCtD
Perphenazine—Hypotension—Vincristine—lymphatic system cancer	0.000734	0.00271	CcSEcCtD
Perphenazine—Dyspnoea—Carmustine—lymphatic system cancer	0.000734	0.00271	CcSEcCtD
Perphenazine—Somnolence—Carmustine—lymphatic system cancer	0.000732	0.0027	CcSEcCtD
Perphenazine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000729	0.0027	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—lymphatic system cancer	0.000729	0.0027	CcSEcCtD
Perphenazine—Decreased appetite—Carmustine—lymphatic system cancer	0.000716	0.00265	CcSEcCtD
Perphenazine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000715	0.00264	CcSEcCtD
Perphenazine—Insomnia—Vincristine—lymphatic system cancer	0.000711	0.00263	CcSEcCtD
Perphenazine—Constipation—Carmustine—lymphatic system cancer	0.000704	0.0026	CcSEcCtD
Perphenazine—Pain—Carmustine—lymphatic system cancer	0.000704	0.0026	CcSEcCtD
Perphenazine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000695	0.00257	CcSEcCtD
Perphenazine—Decreased appetite—Vincristine—lymphatic system cancer	0.000683	0.00252	CcSEcCtD
Perphenazine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000682	0.00252	CcSEcCtD
Perphenazine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00068	0.00251	CcSEcCtD
Perphenazine—Pain—Vincristine—lymphatic system cancer	0.000672	0.00248	CcSEcCtD
Perphenazine—Constipation—Vincristine—lymphatic system cancer	0.000672	0.00248	CcSEcCtD
Perphenazine—Asthma—Methotrexate—lymphatic system cancer	0.00067	0.00248	CcSEcCtD
Perphenazine—Pruritus—Bleomycin—lymphatic system cancer	0.000667	0.00247	CcSEcCtD
Perphenazine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000665	0.00246	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000664	0.00245	CcSEcCtD
Perphenazine—Constipation—Mitoxantrone—lymphatic system cancer	0.000654	0.00242	CcSEcCtD
Perphenazine—Pain—Mitoxantrone—lymphatic system cancer	0.000654	0.00242	CcSEcCtD
Perphenazine—Body temperature increased—Carmustine—lymphatic system cancer	0.000651	0.00241	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000637	0.00235	CcSEcCtD
Perphenazine—Body temperature increased—Vincristine—lymphatic system cancer	0.000621	0.0023	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000612	0.00226	CcSEcCtD
Perphenazine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000608	0.00225	CcSEcCtD
Perphenazine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000606	0.00224	CcSEcCtD
Perphenazine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000605	0.00224	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—lymphatic system cancer	0.000598	0.00221	CcSEcCtD
Perphenazine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000579	0.00214	CcSEcCtD
Perphenazine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000564	0.00208	CcSEcCtD
Perphenazine—Diarrhoea—Carmustine—lymphatic system cancer	0.000563	0.00208	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000558	0.00206	CcSEcCtD
Perphenazine—Dizziness—Carmustine—lymphatic system cancer	0.000544	0.00201	CcSEcCtD
Perphenazine—Diarrhoea—Vincristine—lymphatic system cancer	0.000538	0.00199	CcSEcCtD
Perphenazine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000524	0.00194	CcSEcCtD
Perphenazine—Dizziness—Vincristine—lymphatic system cancer	0.00052	0.00192	CcSEcCtD
Perphenazine—Headache—Carmustine—lymphatic system cancer	0.000516	0.00191	CcSEcCtD
Perphenazine—Headache—Vincristine—lymphatic system cancer	0.000492	0.00182	CcSEcCtD
Perphenazine—Headache—Mitoxantrone—lymphatic system cancer	0.000479	0.00177	CcSEcCtD
Perphenazine—Erythema—Methotrexate—lymphatic system cancer	0.000467	0.00173	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—lymphatic system cancer	0.00044	0.00163	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—lymphatic system cancer	0.000418	0.00155	CcSEcCtD
Perphenazine—Cough—Methotrexate—lymphatic system cancer	0.000408	0.00151	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—lymphatic system cancer	0.000405	0.0015	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—lymphatic system cancer	0.000384	0.00142	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000381	0.00141	CcSEcCtD
Perphenazine—Infection—Methotrexate—lymphatic system cancer	0.000379	0.0014	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—lymphatic system cancer	0.000363	0.00134	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—lymphatic system cancer	0.000356	0.00132	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—lymphatic system cancer	0.000345	0.00127	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00034	0.00126	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—lymphatic system cancer	0.000339	0.00125	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000331	0.00123	CcSEcCtD
Perphenazine—Pain—Methotrexate—lymphatic system cancer	0.000326	0.00121	CcSEcCtD
Perphenazine—Urticaria—Methotrexate—lymphatic system cancer	0.000303	0.00112	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000301	0.00111	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000281	0.00104	CcSEcCtD
Perphenazine—Pruritus—Methotrexate—lymphatic system cancer	0.00027	0.000997	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000261	0.000964	CcSEcCtD
Perphenazine—Dizziness—Methotrexate—lymphatic system cancer	0.000252	0.000932	CcSEcCtD
Perphenazine—Headache—Methotrexate—lymphatic system cancer	0.000239	0.000883	CcSEcCtD
